Abstract
Preimplantation genetic testing for aneuploidy (PGT-A) is associated with significant improvement in ongoing pregnancy rates per transfer, reduction of multiple pregnancies using elective single embryo transfer (eSET), and reduced miscarriage rates in women > 35 years or older. As these improvements have not been observed in women < 35 years old, we sought to investigate whether offering PGT-A to favorable prognosis young women can be counterproductive and lead to suboptimal pregnancy outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
